Poillet-Perez Laura, Jacquet Marine, Hervouet Eric, Gauthier Thierry, Fraichard Annick, Borg Christophe, Pallandre Jean-René, Gonzalez Bruno J, Ramdani Yasmina, Boyer-Guittaut Michaël, Delage-Mourroux Régis, Despouy Gilles
Unité Mixte de Recherche, Interactions Hôte-Greffon-Tumeur, Ingénierie Cellulaire et Génique, Université Bourgogne Franche-Comté, Besançon, France.
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Oncotarget. 2017 Jul 27;8(34):55998-56020. doi: 10.18632/oncotarget.19639. eCollection 2017 Aug 22.
The GABARAPL1 protein belongs to the ATG8 family whose members are involved in autophagy. Our laboratory previously demonstrated that GABARAPL1 associates with autophagic vesicles, regulates autophagic flux and acts as a tumor suppressor protein in breast cancer. In this study, we aimed to determine whether GABARAPL1 conjugation to autophagosomes is necessary for its tumor suppressive functions using the MCF-7 breast cancer cell line overexpressing GABARAPL1 or a G116A mutant, which is unable to be lipidated and associated to autophagosomes. We show that the G116A mutation impaired GABARAPL1 function in autophagosome/lysosome fusion and inhibited lysosome activity but did not alter MTOR and ULK1 activities or tumor growth . Our results demonstrate for the first time that GABARAPL1 plays different regulatory functions during early and late stages of autophagy, independently or not of its conjugation to autophagosomes, but its tumor suppressive function appeared to be independent of its conjugation to autophagic vesicles.
GABARAPL1蛋白属于ATG8家族,其成员参与自噬过程。我们实验室先前已证明,GABARAPL1与自噬小泡相关联,调节自噬通量,并在乳腺癌中作为一种肿瘤抑制蛋白发挥作用。在本研究中,我们旨在通过使用过表达GABARAPL1或G116A突变体(无法进行脂化且与自噬小体不相关)的MCF-7乳腺癌细胞系,来确定GABARAPL1与自噬体的缀合对于其肿瘤抑制功能是否必要。我们发现,G116A突变损害了GABARAPL1在自噬体/溶酶体融合中的功能,并抑制了溶酶体活性,但未改变MTOR和ULK1的活性或肿瘤生长。我们的结果首次证明,GABARAPL1在自噬的早期和晚期发挥不同的调节功能,无论其是否与自噬体缀合,但其肿瘤抑制功能似乎与其与自噬小泡的缀合无关。